Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vismodegib Preceding Mohs Surgery for Basal Cell Carcinoma
NCT01543581Phase 2Completed
- Start
- May 2012
- Primary completion
- Jun 2013
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in basal cell carcinoma (BCC) comparing Vismodegib with Placebo (2 arms). Primary endpoint: Mohs Micrographic Surgery (MMS). Started May 2012; status: completed.
02
Drugs
vismodegib
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT01543581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01543581.